ƒg ƒb ƒv

Œä ˆ¥ ŽA

f—Èēà

ˆãŽtÐ‰î

Œð’ʈēà

‚¨’m‚点

ƒgƒsƒbƒNƒX

Œ’NuÀ

ˆã—ÑŠ’k

ƒŠƒ“ƒNW

‹lˆÄ“à

Œ¤‹†‹ÆÑ

miyashita-clinic-logo-s.jpg
W M  C

Wakeikai   Medical   Corporation   Miyashita   Clinic    (WMC)
       Centers   for  Thyroid  &  Diabetes  &  Allergy  &  Infectious  Diseases    (CTDAI)         

thyroid_center_s_g.jpg
C T D A I

Žå‚ÈŒ¤‹†‹ÆÑ

Discrete characteristics of antibodies raised against thyrotropin receptor-related peptides whose sequences are not conserved in the luteinizing hormone/chorionic gonadotropin receptor.
Murakami M, Miyashita K, Mizuma H, Yamada M, Iriuchijima T, Takeuchi T, Mori M.  
J Clin Endocrinol Metab. 1996 May;81(5):1747-52.

Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus.
Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, Iriuchijima T, Yokoo H, Yoshida I, Tsushima Y, Mori M.
J Clin Invest. 1996 Nov 15;98(10):2228-34.

Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone.
Miyashita K, Murakami M, Iriuchijima T, Takeuchi T, Mori M.
Mol Cell Endocrinol. 1995 Dec 29;115(2):161-7.

Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.
Murakami M, Miyashita K, Kakizaki S, Saito S, Yamada M, Iriuchijima T, Takeuchi T, Mori M.
Eur J Endocrinol. 1995 Jul;133(1):80-6.

Precipitations of thyrotropin receptor-related peptides by immunoglobulin G of patients with Hashimoto's thyroiditis.
Murakami M, Miyashita K, Yamada M, Iriuchijima T, Mori M.
Life Sci. 1994;55(15):1209-7.

[Comparison of immunogenic regions in TSH receptor for Graves' IgG and Hashimoto's IgG].
Murakami M, Miyashita K, Mori M.
Nippon Rinsho. 1994 Apr;52(4):1057-62. Review. Japanese.

Histidyl-proline diketopiperazine. Novel formation that does not originate from thyrotropin-releasing hormone.
Miyashita K, Murakami M, Yamada M, Iriuchijima T, Mori M.
J Biol Chem. 1993 Oct 5;268(28):20863-5.

Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, TA-0910, of the pituitary-thyroid axis in subjects with brain stroke.
Miyashita K, Murakami M, Satoh T, Monden T, Yamada M, Iriuchijima T, Kazihara A, Mori M.
Intern Med. 1993 Sep;32(9):681-5.

Evidence that a soluble form of TSH receptor is present in periferal blood of patients with Graves' disease
Murakami M, Miyashita K, Yamada M, Iriuchijima T, Mori M
80 Years of hashimoto Disease ed. by Nagataki S, Mori T and Torizuka K; Excerpta Medica 1993: 683-685

Identification of immunogenic regions in thyrotoropin receptor for immunoglobulinG of patients with Hashioto thyroiditis
Murakami M, Miyashita K, Yamada M, Iriuchijima T, Mori M
80 Years of hashimoto Disease ed. by Nagataki S, Mori T and Torizuka K; Excerpta Medica 1993: 525-529

Characterization of human thyrotropin receptor-related peptide-like immunoreactivity in peripheral blood of Graves' disease.
Murakami M, Miyashita K, Yamada M, Iriuchijima T, Mori M.
Biochem Biophys Res Commun. 1992 Jul 31;186(2):1074-80.

Thyroid hormones regulate the formation of inositol phosphate in response to thyrotropin-releasing hormone in rat anterior pituitaries.
Iriuchijima T, Michimata T, Miyashita K, Ogiwara T, Yamada M, Murakami M, Mori M.
Neuropeptides. 1992 Jan;21(1):49-53.

TRH-Gly, a precursor of TRH, alters GH secretion in acromegaly.
Mori M, Satoh T, Miyashita K, Yamada M, Murakami M, Iriuchijima T, Ohshima K, Kobayashi I, Kobayashi S.
Life Sci. 1991;49(14):1031-7.

A possible direct precursor of thyrotropin-releasing hormone, pGlu-His-Pro-Gly, stimulates prolactin secretion in anorexia nervosa.
Mori M, Murakami M, Satoh T, Miyashita K, Iriuchijima T, Yamada M, Inukai T, Kobayashi I.
J Clin Endocrinol Metab. 1990 Jul;71(1):252-5.

Stimulation by a TRH precursor, TRH-Gly, of TSH and PRL secretion in rats: effect of starvation.
Mori M, Murakami M, Iriuchijima T, Miyashita K, Satoh T, Monden T, Michimata T, Kobayashi I, Kobayashi S.
Neuropeptides. 1990 Jun;16(2):57-62.

“œ”A•a«ƒAƒ‹ƒuƒ~ƒ“”A‚ð’æ‚·‚鍂ŒŒˆ³Ç—á‚ɑ΂·‚鉖Ž_ƒ}ƒjƒWƒsƒ“‚Ì—L—p«
´…O”VA‹{‰º˜a–çAãŒ´@–LA³“cƒŽjA²“¡‘¥”VA‰iˆä@—²AŽRŒû^ŽjAÎŒ´O•¶A‘哇Šì”ªAX@¹•ü
V–ò‚ƗՏ°@‘æ43Šª@‘æ12†@•½¬6”N12ŒŽ@2549-2553